Quo vadis: from oxidative stress to gamma-glutamyltransferase upregulation to mortality.
作者信息
Mehta Rohini, Birerdinc Aybike, Younossi Zobair
机构信息
Betty and Guy Beatty Obesity and Liver Program, Inova Health System, Falls Church, VA, USA.
出版信息
J Clin Exp Hepatol. 2013 Mar;3(1):2-3. doi: 10.1016/j.jceh.2013.02.004.
Abstract
摘要
相似文献
1
Quo vadis: from oxidative stress to gamma-glutamyltransferase upregulation to mortality.路在何方：从氧化应激到γ-谷氨酰转移酶上调再到死亡
J Clin Exp Hepatol. 2013 Mar;3(1):2-3. doi: 10.1016/j.jceh.2013.02.004.
2
Serum gamma-glutamyltransferase level is associated with serum superoxide dismutase activity and metabolic syndrome in a Japanese population.在日本人群中，血清γ-谷氨酰转移酶水平与血清超氧化物歧化酶活性及代谢综合征相关。
J Gastroenterol. 2012 Feb;47(2):187-94. doi: 10.1007/s00535-011-0477-8. Epub 2011 Oct 6.
3
Association between serum gamma-glutamyltransferase and oxidative stress related factors.
Hepatogastroenterology. 2008 Jan-Feb;55(81):50-3.
4
What does serum γ-glutamyltransferase tell us as a cardiometabolic risk marker?血清γ-谷氨酰转移酶作为一种心脏代谢风险标志物能告诉我们什么？
Ann Clin Biochem. 2016 May;53(Pt 3):312-32. doi: 10.1177/0004563215597010. Epub 2015 Jul 2.
5
Endothelial (DYS)Function: Quo vadis, Cur vadis.内皮（功能障碍）功能：向何处去，因何而去。
J Hypertens. 2012 Jul;30(7):1321-4. doi: 10.1097/HJH.0b013e32835522e2.
6
Meningioma research-status quo and quo vadis.脑膜瘤研究现状与未来走向
Chin Clin Oncol. 2017 Jul;6(Suppl 1):S1. doi: 10.21037/cco.2017.06.21.
7
Quo venis quo vadis: the evolution of arthroscopy.你来何处，去往何方：关节镜检查的发展历程
Arthroscopy. 1999 Sep;15(6):680-5. doi: 10.1016/s0749-8063(99)00141-3.
8
Stress ulcer prophylaxis--quo vadis?应激性溃疡的预防——路在何方？
Intensive Care Med. 1994 May;20(5):311-3. doi: 10.1007/BF01720900.
9
Smoking-Associated Mortality in Spain: Quo Vadis?西班牙吸烟相关死亡率：何去何从？
Arch Bronconeumol (Engl Ed). 2021 Jan 30. doi: 10.1016/j.arbres.2020.12.035.
10
Quo Vadis…Pneumonia.路在何方……肺炎。
Pulmonology. 2019 Mar-Apr;25(2):65. doi: 10.1016/j.pulmoe.2019.03.004.
本文引用的文献
1
Serum γ-glutamyltranspeptidase predicts all-cause, cardiovascular and liver mortality in older adults.血清γ-谷氨酰转肽酶可预测老年人的全因死亡率、心血管死亡率和肝脏死亡率。
J Clin Exp Hepatol. 2013 Mar 1;3(1):4-11. doi: 10.1016/j.jceh.2012.10.004.
2
Role of GGT in diagnosis of metabolic syndrome: a clinic-based cross-sectional survey.GGT 在代谢综合征诊断中的作用：一项基于临床的横断面调查。
Indian J Med Res. 2010 Jul;132:56-61.
3
Gamma-glutamyl transferase: a novel cardiovascular risk biomarker.γ-谷氨酰转移酶：一种新型心血管风险生物标志物。
Prev Cardiol. 2010 Winter;13(1):36-41. doi: 10.1111/j.1751-7141.2009.00054.x.
4
Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.γ-谷氨酰转移酶与代谢综合征、心血管疾病及死亡风险：弗雷明汉心脏研究
Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):127-33. doi: 10.1161/01.ATV.0000251993.20372.40. Epub 2006 Nov 9.
5
Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women.血清γ-谷氨酰转移酶可预测28838名中年男性和女性中的非致命性心肌梗死及致命性冠心病。
Eur Heart J. 2006 Sep;27(18):2170-6. doi: 10.1093/eurheartj/ehl086. Epub 2006 Jun 13.
6
Gamma-glutamyl transpeptidase in glutathione biosynthesis.谷胱甘肽生物合成中的γ-谷氨酰转肽酶
Methods Enzymol. 2005;401:468-83. doi: 10.1016/S0076-6879(05)01028-1.
7
Age-related oxidative stress and antioxidant parameters in middle-aged and older European subjects: the ZENITH study.欧洲中老年受试者与年龄相关的氧化应激和抗氧化参数：ZENITH研究
Eur J Clin Nutr. 2005 Nov;59 Suppl 2:S58-62. doi: 10.1038/sj.ejcn.1602300.
8
Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque.γ-谷氨酰转移酶、动脉粥样硬化与心血管疾病：引发斑块内的氧化应激
Circulation. 2005 Oct 4;112(14):2078-80. doi: 10.1161/CIRCULATIONAHA.105.571919.
9
Gamma-glutamyl transferase and metabolic risk factors for cardiovascular disease.γ-谷氨酰转移酶与心血管疾病的代谢危险因素
Intern Med. 2005 Jun;44(6):538-41. doi: 10.2169/internalmedicine.44.538.
10
Is serum gamma glutamyltransferase a marker of oxidative stress?血清γ-谷氨酰转移酶是氧化应激的标志物吗？
Free Radic Res. 2004 Jun;38(6):535-9. doi: 10.1080/10715760410001694026.
Zotero 插件